IVA - Inventiva GAAP EPS of -Euro1.31 revenue of Euro1.9M
2023-09-28 16:28:45 ET
More on Inventiva
- Inventiva: An Untenable Cash Position Despite Enviable Data
- Inventiva and Hepalys Pharma to develop and commercialize Lanifibranor in Japan and South Korea
- Inventiva announced €35.7M funding, eyes future raise to meet obligations
- Seeking Alpha’s Quant Rating on Inventiva
- Historical earnings data for Inventiva
For further details see:
Inventiva GAAP EPS of -€1.31, revenue of €1.9M